Open Label Extension

PHASE3CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

January 10, 2005

Primary Completion Date

October 27, 2006

Study Completion Date

October 27, 2006

Conditions
Osteoporosis
Interventions
DRUG

ALX1-11

Trial Locations (12)

48236

'Michigan Bone & Mineral Clinic, Detroit

57201

'Brown Clinic, Watertown

57701

'Rapid City Medical Center, Rapid City

58103

Michael J. Lillestol, Fargo

58501

'Odyssey Research Services, Bismarck

58701

'Odyssey Research Services, Minot

60637

'The University of Chicago, Chicago

90211

'Osteoporosis Medical Center, Beverly Hills

05401

'Fletcher Allan Health Center, UHC Campus 1, Burlington

C1012AAR

'IDIM, Buenos Aires

C1117ABH

'Centro Médico T.I.E.M.P.O, Buenos Aires

C1114AAI

'Centro de Osteopatias Medicas, Capital Federal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT00172120 - Open Label Extension | Biotech Hunter | Biotech Hunter